EDUCATION:
1976 — Ph.D., Biochemistry, City University of New York
1970 — B.S., Chemistry, City College of New York
EMPLOYMENT:
2016- Present — Visiting Professor, Department of Pharmacology and Toxicology Ernest Mario School of Pharmacy Rutgers University
2015- Present — President, Natural Philosophy Institute Inc. Rockville MD
2009-2015 — Director Division of Physiological and Pathological Sciences, Center for Scientific Review, National Institutes of Health
2014 — Interim Vice President for Research, Uniformed Services University of the Health Sciences Bethesda MD.
2010-2011 — Acting Director, Division of AIDS, Behavioral and Population Sciences Center for Scientific Review, NIH
2005-2009 — Professor of Environmental and Occupational Health Sciences, Graduate School of Public Health Director, Molecular Carcinogenesis Program, University of Pittsburgh Cancer Institute
1998-2009 — Scientific Director, Genetics Research Institute Milan Italy
1997-1998 — Visiting Scientist, Epidemiology Research Institute University of Milan, Milan Italy
1992-1997 — Professor, Department of Environmental Medicine New York University Medical Center New York, New York
1987-1992 — Associate Professor, Department of Environmental Medicine New York University Medical Center
1979-1987 — Assistant Professor,, Department of Environmental Medicine New York University Medical Center
1975-1979 — Post-doctoral Trainee and Associate Research Scientist Department of Environmental Medicine New York University Medical Center
1970‑1975 — Lecturer, Department of Chemistry City College of New York New York, New York
INVITED PRESENTATIONS:
“Biological Pointers to a Creator” Presented at the second Capturing Christianity Conference, Houston Texas, August 5, 2022
“Theory, Teleology and Theology in Biology” Presented at the second Capturing Christianity Conference, Houston Texas, August 6, 2022
“An Argument for God from Biology” Presented at the first Capturing Christianity Conference, Houston Texas, August 29 2021.
“Biological Design, Evolution, Abiogenesis and God” Presented at the first Capturing Christianity Conference, Houston Texas, August 30, 2021.
“Intrinsic Biological Intelligence and Design.” Presented at the Annual Meeting of the American Scientific Affiliation July 30, 2018.
“The Teleological Biochemistry of Evolution” Presented at the Annual Meeting of the American Scientific Affiliation July 29, 2017.
“So Many Cousins: The Biology and Theology of Race and Diversity in Modern Humans” Presented at the Smitsonian Hall of Human Origins, “Hot Topics Discussion, August 18, 2017.
“New Ideas in Evolutionary Biology: A Christian Perspective” Presented at the June 24th meeting of the American Scientific Association Washington DC Metro Section http://www2.asa3.org/movies/WDCASA2016Garte.mp4
“Humility, Science and Faith” Presented at the Lenten Discussion at Rockville United Methodist Church, Feb 19, 2016.
“Science and Faith” A 10 week course given at Rockville United Methodist Church from September through November 2014. Co-taught with Mark Meredith.
“The Grants Process at NIH” Presented at the Vice President for Research Seminar at USUSH, September 10,2014
“My Journey from Atheism to Faith” Presented at the Biologos Celebration of Faith Workshop, April 26, 2013, New York, NY.
“Evolutionary Thinking and the Christian Faith” A two part symposium organized at the Rockville United Methodist Church, July 7 and July 14, 2013.
“Peer Review of Toxicology and Environmental Health Related Applications.” Presented at Society of Toxicology Annual Meeting. Washington DC. Mar 9, 2011.
“The Peer Review Process at CSR” Presented at the National Cancer Institute Mar 3 2009
“Environment and Health: Recent Global Trends” Presented at the Workshop on Environment and Health at The International Environment Festival, Milan Italy, June 5, 2008.
“Environmental Toxicology in Humans: From Molecular Epidemiology to Mechanism.” Seminar presented at the Department of Environmental and Occupational Health, School of Public Health, University of Pittsburgh Nov 19, 2007.
“WHERE WE STAND:A Surprising Look at the Real State of Our Planet” Televised (CSPAN) Seminar and Panel Discussion at the American Enterprise Institute, Washington DC. Nov 3, 2007
“Genetic Susceptibility to Benzene Toxicity in Humans” Presented at Public Health Applications Of Human Biomonitoring An International Workshop sponsored by the U.S. Environmental Protection Agency and the International Council of Chemical Associations Minneapolis MN September 24 2007
“From Molecular Epidemiology to Observational Mechanistic Analysis” Presented at the UPCI annual Retreat, Johnstown PA, June 22, 2006
“The GSEC Project: State of the Art” Presented at the ECNIS Project Workshop, Torino Italy, May 29 2006
“Metabolic Genes As Markers Of Biochemical Susceptibility: A Mechanistic Approach”. Presented at the 35th Annual Meeting of the European Environmental Mutagen Society Environment and human genetic disease – Causes, mechanisms and effects July 4, 2005 Kos, Greece.
“Biochemical Susceptibility: An Approach to the Genetics of Environmental Carcinogenesis”. University of Pittsburgh School of Public Health, Department of Environmental and Occupational Health. March 29, 2005.
“Metabolic, Genotoxic and Genetic Susceptibility Biomarkers in Bulgarian Petrochemical Workers Exposed to Benzene”. Presented at the Symposium on Recent Advances in Benzene Toxicity Munich Germany October 11, 2004.
“Race and Genetic Ancestry in Biomedical Research” Presented at the Meeting on Human Genetic Variation: from Evolution to Health. Italian Institute of Anthropology Univerity of Rome “La Sapienza” Nov 19, 2004.
“Racial categorization and genetic variation” Presented at the Genetic Variation Consortium of the ELSI program, NHGRI, Bethesda MD. July 12, 2004.
“Genetic susceptibility to environmental carcinogens – the GSEC database” 1st International Conference on Molecular Research in Environmental Medicine, Duesseldorf, Germany March 18, 2004
“Polymorphisms in metabolic genes” 7th International Symposium on Molecular Basis of Predictive Oncology and Intervention Strategies Nice, France Feb 7, 2004
“Genetics of Race” Meeting on Bioethics: Between Science and Rights. University of Sassari Nuoro, Sardinia, Italy, Oct. 31, 2003.
“Genetics and the Definition of Race” 4th UMDNJ/RWJMS Conference on Culturally Competent Care. Philadelphia PA. September 20, 2003.
“Genetics and Race Definition: A Public Health Perspective” Seminar presented at University of Pittsburgh School of Public Health, August 6, 2003.
“Race and Genetics” Presented at the WEACT Workshop on Human Genetics, Environment and Communities of Color, New York, NY. February 5, 2002.
“Metabolic Gene-Environment Interaction In Human Carcinogenesis” Presented at the Danish Ministry of Health, Research Center for Environmental Health Meeting, Copenhagen, Denmark, November 9, 2001.
“A Re-Assessment of the Role of Metabolic Susceptibility Genes in Human Cancer” Presented at the Department of Envionmental Health, Johns Hopkins School of Public Health, Baltimore MD, February 19, 2001.
“Polymorphisms in Metabolic Genes: Population Frequencies and Cancer Susceptibility” Presented at the Mario Negri Institute, Milan, Italy, January 22, 2001.
“From the Laboratory to Epidemiology” Presented at the Italian Association of Epidemiology, Rome Italy, October 19, 2000.
“Molecular Epidemiology of Cancer in African Americans” Presented at the Pulmonology Division, Harlem Hospital, May 16, 2000.
“Frequency of Common Polymorphisms in Different Populations, and their Association with Chemical Exposures” Presented at the annual meeting of the International Epidemiological Association Sept. 3 1999, Florence Italy.
“Polymorphisms in Metabolic Genes and Susceptibility to Cancer” Seminar at the Department of Medical Genetics, University of Milano, Milan, Italy, Jan 21, 1999.
“Metabolic Gene Polymorphisms and interaction with Environmental Exposure” Presented at the Course on Carcinogenesis: Mechanisms of Action and Estimate of Risk. Superior Institute of Health, Rome, Italy, Nov. 17, 1999
“Genetic Susceptibility to Cancer” Seminar presented at Institute of Cancer Research University of Genova Italy Mar 30, 1999.
“Metabolic Gene Polymorphisms and Individual Susceptibility to Environmental Toxicants” Presented at the 24th Annual Toxicology Forum, Washington DC., February 1, 1999.
“Population Genetics of Polymorphisms in Metabolic Susceptibility Genes” Presented at the Annual Meeting of the Italian Environmental Mutagenesis Society, Cortona Italy, October 8, 1998.
“Genotype and Expression of Metabolic Genes as Markers of Susceptibility and Exposure” Seminar presented at EOHSI, Piscataway N.J. Sept 28, 1998.
“Health Effects of Butadiene:Informing the Regulatory Process” Presented at the Joint HEI/EC Directorate General XI Workshop on Butadiene, Brussels Belgium, June 29, 1998.
“Metabolic Gene Polymorphisms in Susceptibility to Benzene Toxicity” Presented at the Biomed2/Benzene European Project Meeting Genova Italy, May 19, 1998.
“Standardization of DNA Techniques for Biomarker Studies” Presented at the Second Meeting of the Italian Coordinating group of the EPIC Study, Florence, Italy November 13, 1997.
“Gene-Environment Interactions in Biomarkers of Exposure and Susceptibility” Seminar presented at theDepartment of Occupational Medicine, University of Milan, Italy, June 20, 1997.
“Gene-Environmental Interactions in Molecular Epidemiology” Seminar presented at San Raffaele Scientific Institute, Milan Italy, Dec. 10, 1996.
“Gene Environment Interaction in the Application of Biomarkers of Exposure and Susceptibility” Seminar presented at the Occupational Medicine Institute, Umiversity of Milan, Mar 6, 1996
“Metabolic Genes as Biomarkers of Carcinogen Susceptibility and Exposure” Seminar presented at IARC, Lyon France, Mar. 22, 1996.
“Gene-Environment Interaction related to Cancer Susceptibility Genes” Seminar presented at the University of Torino, Italy, Mar 21, 1996.
”Gene-Environment Interactions in the use of Biomarkers of Cancer Susceptibility in Epidemiology” Presented at the IARC Workshop “Methodological Issues in the Use of Biomarkers in Cancer Epidemiology” Lyon France, February 22, 1996.
“Ethnic Differences in Cancer Susceptibility Genes” Presented at the US/Italy Workshop “Molecular Epidemiology” Portofino Italy, November 18, 1995.
“Enhanced Risk of Adenocarcinoma of the Lung and Prostate in African American Smokers Carrying a Novel Cytochrome P450 (CYP1A1) Polymoprphism.” Presented at the 15th International Symposium on Polycyclic Aromatic Hydrocarbons, Ispra Italy, September 21, 1995.
“Genes in Molecular Epidemiology”. Seminar presented at the Skirball Institute and Kaplan Comprehensiver Cancer Center Experimental Oncology Seminar Series, New York University Medical Center, New York, N.Y. June 14, 1995.
“CYP1A1 Gene as a Biomarker for Environmental Exposure and Individual Susceptibility” Seminar presented at the American Health Foundation, Valhalla New York Dec. 5, 1994.
“An African American Specific CYP1A1 Polymorphism, and Cancer Susceptibility”. Seminar presented at Ciba Corning Inc., Walpole Mass. Oct 5, 1994.
“Racial Differences in CYP1A1 genotype and function” Presented at the International Symposium on Human health and the Environment: Mechanisms of Toxicity and Biomarkers to Assess Adverse Effects of Chemicals. Salsomaggiore Italy, Sept 27, 1994.
“CYP1A1 Genotype and Expression as a Novel Biomarker” Presented at the 24th Meeting of the European Environmental Mutagenesis Society Meeting on “Human Biomonitoring in Assessment of Genetic Risk”, Posnan, Poland Sept.3, 1994.
“Gene Expression Assays as Biomarkers for Hydrocarbon Exposure”. Seminar presented at the Institute of Occupational Medicine Lodz, Poland, August 31, 1994.
“Gene Expression and Genotype in Molecular Epidemiology” Seminar presented at the Johns Hopkins School of Public Health, Baltimore, MD Mar. 18, 1994.
“A Novel CYP1A1 in African Americans: Susceptibility to Lung Cancer” Presented at the U.S.-Japan Joint Environmental Panel Conference “Novel Methods to Assess Environmental Mutagens and Carcinogens”, Harriman, New York, Jan 27, 1994.
“Gene Alterations in Models of Environmental Carcinogenesis and Molecular Epidemiology”. Seminar Presented at University of Cinncinati Department of Environmental Health, January 13, 1994.
“The Environmental Carcinogenesis Program” Presented at the Progress in Cancer Seminar, Kaplan Comprehensive Cancer Center, New York University, NY April 23 1992
“Cytochrome P450 Gene Expression as a Marker for Toxic Exposure” Presented at the International Symposium on “Diet, Biochemical Markers and Cancer”, Malmo, Sweden, October 23, 1991.
“Specificity and Timing of c-myc Gene Amplification in Radiation-induced Rat Skin Tumors.” Presented at an NCI workshop on “The Function, Specificity and Induction of Cellulat Proteins Formed in Response to Damage from Ionizing Radiation.” Bethesda Md. Sept 5-6, 1991.
“Role of Oncogenes in Progression of Experimental Neoplasia in Vivo and in Vitro” Seminar presented At Pennsylvania State Medical College, Hershey PA. March 11, 1991.
“Gene Expression Assays as Molecular Markers for Epidemiology and Environmental Toxicology” Seminar presented at the Department of Environmental and Community Medicine, University of Medicine and Dentistry of New Jersey. February 6, 1991.
“Activation of c-myc Oncogene as a Late Stage Event in Radiation Carcinogenesis. Seminar presented at Department of Radiation Oncology, University of Pennsylvania, November 16, 1989.
“Temporal Aspects of Oncogene Activation in Experimental Carcinogenesis”. Presented at the Conference on Critical Target Genes in Chemical Carcinogenesis. Research Triangle Park, North Carolina, September 10‑14, 1989.
“Oncogene Activation as a Toxicological Endpoint: Experimental and Theoretical Approaches”. Presented at the Spring Symposium “Oncogenes” of Mid‑Atlantic Society of Toxicology. Wilmington, Delaware, May 17, 1989.
“Environmental Carcinogenesis ‑ A Rational View”. Presented at the Annual Toxicology Symposium “Update: Environmental Contaminants and Cancer”. Montclair State College, Upper Montclair, New Jersey, April 28, 1989.
“Oncogene Activation in Environmental Carcinogenesis”. Seminar presented at Eppley Cancer Research Institute. Omaha, Nebraska, April 13, 1989.
“Oncogene Activation and The Biology of Experimental Carcinogenesis”. Seminar presented at Chemical Industry Institute of Toxicology”, March 30, 1989.
“Oncogene Activation and Tumor Progression”. Seminar presented at Department Pathology, University of North Carolina, Chapel Hill, North Carolina, March31, 1989.
“Oncogene Activation in Rat Nasal Carcinomas”. Presented at Symposium on Nasal Carcinogenesis in Rodents. Relevance for Human Health Risk. Veldhoven, Netherlands, October 24‑28, 1988.
“Oncogene Activation in Carcinogen‑induced Nasal and Skin Tumors”. Presented at U.S.‑Japan Joint Environmental Panel Conference on Molecular Approaches to Environmental Mutagenesis and Carcinogenesis. Yokohama, Japan, July 24‑26, 1988.
“Oncogenes and Mechanisms of Carcinogenesis”. Seminar presented at City College of New York, Department of Microbiology. May 16, 1988.
“Oncogene Activation in Experimental Carcinogenesis”. Mount Sinai School of Medicine, Department of Anatomy Seminar, January 6, 1988.
“Cellular Oncogenes” Seminar presented at the Department of Chemistry, Pace University, New York, NY March 9 1988
“Oncogene Activation in Environmental Carcinogenesis”. Rider College, Princeton, New Jersey, April 3, 1987.
“Protease Inhibitor Suppression of ras Oncogene Transformation”. National Cancer Institute Workshop on Protease Inhibitors as Cancer Chemopreventive Agents”. Dedham, Massachusetts, December 15, 1987.
“Oncogene Activation in Multistage Carcinogenesis”. American College of Toxicology Annual Meeting. Baltimore, Maryland, December 8, 1987.
“Oncogenes in Experimental Carcinogenesis: In Vivo and In Vitro Models”. Harvard School of Public Health, Seminar, October 21, 1987.
PROFESSIONAL AND VOLNTEER* ACTIVITIES:
*2017-Present — Editor-in-Chief, God and Nature magazine – American Scientific Affiliation
*2017- 19 — Commissioner, Environment Commission, City of Rockville
*2017-Present — Fellow of the American Scientific Affiliation
2*016-2020 Lay Leader, United Methodist Church, Rockville MD.
*2015-Present — Vice President, Washington DC Metropolitan Area Section of the American Scientific Affiliation (ASA)
*2015-Present. Grants Officer, RockvilleHelp Inc. (A nonprofit local charity)
2014-2015 — John Templeton Foundation Board of Advisors
2015-2016 — Consultant for John Templeton Foundation Project on Peer Review.
2013-2014 — Reviewer for the John Templeton Foundation Grants Program
2011-2012 — Consultant for the Biologos Foundation “Evolution and Christian Faith” Grants Program
2011 — Chair and Organizer, NIH Working Group for Environmental Health and Toxicology Working Group
2008 — Special Review Committee for NIH Revision Awards for Studying Interactions Among Social, Behavioral, and Genetic Factors in Health
2007 — Invited Participant at EPA State-of-the-Science Workshop on Low Dose-Response Extrapolation in Human Health Risk Assessment. Johns Hopkins School of Public Health.
2007 — Participant and Discussant at “REACH: A New EU Approach to Chemical Safety: Lessons for the United States?” A conference on the European Union (EU) regulation providing for Registration, Evaluation, Authorization and restriction of CHemicals (REACH) University of Pittsburgh.
2006 — Moderator, Session on Gene-Environment Interactions, Science2006, University of Pittsburgh.
2006 — Participant at C-Change Research Summit
2006 — Hillman Fellow for Innovative Cancer Research
2005 — Senior Guest Editor, Mutation Research, Fundamental and Molecular Mechanisms of Mutagenesis
2005 — Phase II Reviewer, NIEHS Superfund Program Project Grants Review Program
2004-2009 — Editorial Board, Cancer Detection and Prevention.
2004 — Session Chair, ICT X Satellite Meeting on Molecular Epidemiology Porvoo, Finland
2004 — Member Organizing Committee ICT X Satellite Meeting on Molecular Epidemiology
2003-2004 — Member, Genetic Variation Consortium, ELSI Program, NHGRI
2001 — National Cancer Institute (NCI) Cancer Center Review Committee, Fred Hutchison Cancer Center, University of Washington
2001 — Chair, Plenary session, IARC Workshop on Mechanistic Considerations in the Design and Interpretation of Molecular Epidemiologic Studies of Cancer, Lyon
2001 — European Commission Evaluation Panel for Joint Dedicated Call on Endocrine Disrupters
2001 — Consultant and Rapporteur for Workshop and Guidelines on Pharmacogenetics and Ethics, GlaxoSmithKline, Verona Italy
2000 — Chair, Session on Molecular Epidemiology, at the London Symposium on Evaluation of Butadiene, Isoprene and Chloroprene Health Risk
1999-2009 — International Committee for CYP Gene Nomenclature
1999-2005 — Lecturer, IARC/ISI International Course in Molecular Epidemiology
1999 — CoChair for NIEHS Superfund Program Project Grants Review Program
1998 — Observer at IARC Monograph Meeting on Re-Evaluation of the Carcinogenicity of some Organic Compounds
1997-2009 — Chair, Advisory Panel for Study on Genetic Susceptibility to Environmental Carcinogens
1997-2004 Coordinating Committee for the Italian EPIC Study
1996-7 — National Cancer Institute (NCI) Cancer Center Review Committee for the University of Kentucky.
1996 — Chair, Workshop on Transitional Epidemiology Studies for 1,3- Butadiene, Health Effects Institute (HEI)
1996 — Chair, Plenary Session on “How will Biomarkers of Events at the Molecular Level be Useful in Addressing Enviromental Concerns?” HEI Annual Conference
1994 — Chair, Review Panel for Health Effects Institute RFA 93-1
1993-2000 — Research Committee, Health Effects Institute
1993-96 — Organizing Committee for IARC Workshop on “Methodological Issues in the Use of Biological Markers of Exposure in Epidemiology”
1992-95 — State Legislative Committee for the American Association for Cancer Research, Chair, New York City Subcommittee.
1992 — Scientific Advisory Panel, Chemical Industry Institute of Toxicology
1992 — Discussion Leader, Task Force for Activities and Membership Development in Carcinogenesis, American Association for Cancer Research (AACR)
1992 — Chair, Special Review Committee, National Collaborative Chemoprevention Project, NCI
1992 — Chair, Program Project Review Committee for NCI at American Health Foundation
1991 — Co-Chair, Session on “Genetic Alterations in Multistep Carcinogenesis” Annual meeting of the AACR.
1990-95 — Board of Scientific Advisors, Cancer Prevention Research Institute
1990 — Program Project Site Visit Committee for the NCI Louisiana State University
1990 — Chemical Pathology Study Section
1989 — Co-Chair, Session on “Oncogenes in Carcinogenesis” at the annual meeting of the AACR.
1988-92 — Local Institutional Review Committee, American Cancer Society
1988-90 — Scientific Advisory Board of Cancer Information Dissemination and Analysis Center – Carcinogenesis and Cancer Biology
1988-89 — Chair, Molecular Biology Section, Program Committee for the AACR
1988 — Special Review Committee for Genetic Alterations in Bladder Carcinogenesis for NCI
1988-96 — Congressman Gilman’s Environmental Advisory Committee
1988 — Special Review Committee for the National Institute of Child Health and Human Development
1987 — Special Review Committee for the National Chemoprevention Project of NCI
1987 — Program Project Site Visit Committee for NCI at University of North Carolina
1987 — Co-Chair, Session on “Oncogenes” at the annual meeting of the AACR
1987 — Program Project Site Visit Committee for NCI at Southern Research Institute
1986 — Co-Chair, Session on “DNA Repair and Transformation” at the Annual Meeting of the Environmental Mutagen Society
AWARDS
2022 Distinguished Career Award in Biochemistry. Washington Academy of Sciences.
2014 — Exceptional Service Award and Medal from the Uniformed Services University of the Health Sciences.
2014 — NIH Director’s Award for Rescheduling Peer Review meetings after the Government Shutdown
2013 — Office of the Director Award (NIH) for participation in the Review Policy Committee Working Group on Resubmission Policy
2009 — Above and Beyond Certificate of Appreciation, Director, NIH
COMMITTEES
National Institutes of Health
Review Policy Committee (RPC)
RPC Steering Committee
RPC Subcommittee on Resubmission Policy
RPC Subcommittee on Peer Review Quality Assessment (Chair)
National Institute of Environmental Health Sciences (NIEHS) Review Branch Assessment Working Group
Center for Scientific Review (CSR) Outreach Committee (Chair)
CSR Information Technology Steering Committee (Co Chair)
Employee Promotions Committee (Chair)
Organizing Committee for the Joint RPC/PLC Retreat
Working Group on Peri Council Issues for the Joint RPC/PLC Retreat (Chair)
University of Pittsburgh:
Program Director For Molecular Carcinogenesis, Medical Center
Marketing Committee, School of Public Health
Rutgers University:
Member International Affairs Committee
Chair, Ad hoc committee on Shelby Amendment
Molecular Epidemiology Search Committee
New York University:
Deputy Director – Institute of Environmental Medicine
Program Director – Environmental Carcinogenesis, Kaplan Comprehensive Cancer Center
Program Director – Research in Chemical and Physical Carcinogenesis, Environmental Health Sciences Center
Director ‑ Laboratory of Molecular Oncology
Chair ‑ Biological Safety Committee
Departmental Internal Advisory Committee
Ad Hoc Committee for Review of the Kaplan Comprehensive Cancer Center
Chair – Departmental Committee on Ethics in Research
Departmental Chair Search Committee
Exploratory Studies Grant Committee
Graduate Steering Committee
Departmental Internal Advisory Committee
Faculty Search Committee
Committee on Ethics in Research
Cancer Center Management Group
CONSULTANCIES
Cahill, Gordon, and Reindel
Goldman, Hafetz.
Burns, White and Hickton
Biologos Foundation
John Templeton Foundation
MISCELLANEOUS
h Index = 59 (meaning that 59 of my (215) publications have been cited at least 59 times)
Journal Reviewer for: Cancer Research, Carcinogenesis, Proceedings of the National Academy of Sciences, Molecular Carcinogenesis, Journal of Investigative Dermatology, Journal of Environmental and Public Health, Environmental Health Perspectives, Cancer Epidemiology, Biomarkers and Prevention, Chem. Biol. Interact Biochem. Biophys. Res. Commun Cancer Lett J. Theor. Biol J. Cancer Res. Clin. Oncol J. Tox. and Environ Health International Journal of Cancer Biomarkers Mutation Research J. Toxicology and Environmental Health..
Special Grant Reviewer for the National Cancer Institute, National Insitutue of Environmental Health Sciences, U.S. Department of Agriculture and Hudson River Foundation, CONSOLIDER Ingenio Program of the Spanish Secretary for Science and Technology, AIRC – Associazione Italiana Ricerca Cancro (Italian Association for Cancer Research), Dutch Cancer Society
The Executive Summit, Leadership Training Course from Brookings Executive Education
Member of the Cosmos Club, Washington DC.
EDITORIAL BOARDS
Perspectives in Science and Christian Faith
BioCosmos
Journal of Cancer Research and Clinical Oncology
Carcinogenesis
Cancer Detection and Prevention
HISTORY OF EXTERNAL GRANT SUPPORT:
As Principal Investigator – US Grants
National Cancer Institute, Grant #CA23806 “Biochemical Mechanisms of Tumor Promotion” 07/79-06/82, $85,000
American Cancer Society, Grant IN-14X (Seed Grant) “Oncogenes in Tumor Promotion” 09/82-01/83, $5,000
National Cancer Institute, Grant #CA33874 “Phorbol Esters and a Phospholipid Ca Dependent Protein Kinase” 05/84-04/85, $48,693
National Cancer Institute, Grant #CA36342 “Transforming Genes in Inhalation Carcinogenesis” 07/84-06/92, $859,418
National Institute of Environmental Health Sciences, Grant #ES03563 “Inhalation Carcinogenesis” (PROGRAM PROJECT), Component 4 – “Molecular Characterization of Active Oncogenes in Rat Nasal Tumors Induced by Inhalation of Direct-Acting Carcinogens” 12/84-11/88, $273,873
National Institute of Environmental Health Sciences, Grant #ES03847 Specialized Center of Research (SCOR) in “Genetic Toxicology,” Component 2 – “Specificity of Genotoxic Carcinogens in Oncogene Activation in Mouse Skin Tumors”. 12/85-11/88, $117,930
National Cancer Institute, Grant #CA43199 “Oncogene Activation in Radiation Carcinogenesis” 07/86-3/95, $870,847
National Institute of Environmental Health Sciences, Grant #ES04895 “Methods to Detect and Predict Human Exposure to Toxic Superfund Chemicals”. (PROGRAM PROJECT), Component 3 – “Molecular Assays for Toxicant Exposure” 09/88-8/95, $581,464
National Institute of Environmental Health Sciences, Grant ES05294 “Molecular Toxicology of Environmental Carcinogens” (PROGRAM PROJECT in collaboration with F. Perera, Columbia Univ.) “Analysis of P-450 Gene Expression in Human Lymphocytes” 12/1/89 – 11/30/94, $67,725
National Cancer Institute, Grant #CA52925 “Protease Inhibitor Suppression of Oncogene Function” 8/1/90 – 7/31/93, $312,183
National Cancer Institute, Grant #T32CA09664 “Training Grant in Environmental and Preventive Oncology” 7/1/91 – 6/30/96, $807,420
National Institute of Environmental Health Sciences “Research in Environmental Health Sciences” (CENTER GRANT) Supplement – “Lung Cancer Susceptibility Gene in African-Americans” 11/1/93 – 10/31/94, $75,000
National Institute of Environmental Health Sciences #ES08363 “CYP1A1 As A Marker of Exposure and Susceptibility” 7/1/97 – 6/30/01 $597,078
National Institute of Human Genome Research, ELSI Program “Implications of Genomics Research on Racial Definition” 7/1/02 – 6/30/04 $100,000
American Chemistry Council “Biomarkers in Human Benzene Exposure” 9/1/03 – 8/31/07, $296,000
New Jersey State Commission on Cancer Research 05-1964-CCR-EO “Breast Cancer and Estrogens in African Americans” 6/1/05-5/31/06 $49,500
Pittsburgh Foundation “Hormone-Gene-Environment Interactions In Breast Cancer Risk For African Americans” 7/01/06 – 6/30/08 $65,000
Henry Hillman Foundation Hillman Fellow for Innovative Cancer Research “Interaction Bwetween Genetic Factors and Environmental Exposures in Human Cancer Causation” 1/01/06-12/31/07 $96,499
University of Pittsburgh Head and Neck SPORE Pilot Project Grant “Hypermethylation of Tumor Suppressor Genes in Secondary SCCHN in Relation to Smoking” 3/07-2/08 $74,250
National Cancer Institute P20CA132385 Environmental Oncology Partnership between Hampton University (A Historically African American College) and UPCI 09/01/07-06/30/09 $400,297
AMGEN “Natural history of myelodisplastic syndrome” 09/01/07-12/31/08, $254,397 John Templeton Foundation Grant #57657 A New Biology of Spiritual Information 9/15 – 8/17 $195,000
As Collaborator in MultiCenter European Projects (Genetics Research Institute):
European Commission BIOMED II – BMH4-CT98-3785 Franco Merlo (Tumor Institute, Genoa) P.I. (Subcontract To Genetics Research Institute) “Exposure to Low Levels of Benzene, Interindividual Biological Variability, and Cancer Risk: A Multicentre European Study.” 9/1/99 – 8/31/02 £ 52,964,888 (€27,357.90)
Italian Association for Cancer Research (AIRC) Domenico Palli (Azienda Ospedaliera Careggi, Florence Italy) P.I. (Subcontract To Genetics Research Institute) “Study of the Italian EPIC Cohort” 9/1/98 – 8/31/00 £70,000,000 (€36,157.02)
European Commission Fifth Framework Program – QLK4-CT-1999-00927 Paolo Vineis (University of Torino) P.I. (Subcontract To Genetics Research Institute) “Molecular Changes And Genetic Susceptibility In Relation To Air Pollution And Environmental Tobacco Smoke: A Case-Cohort Study In Non-Smokers Nested In The EPIC Investigation” 4/1/00-3/31/03 £ 64,595,903 (€33,365.65)
European Commission Fifth Framework Program – QLK4-CT-2000-00091 Peter Farmer Medical Research Council Leicester UK (Subcontract To Genetics Research Institute) “Effects of PAHs in Environmental Pollution on Exogenous and Endogenous DNA Damage” 4/1/01-3/31/04 £331,752,960 (€171,360)
European Commission Sixth Framework Program – Contract Number 513943 Konrad Rydzynski (Nofer Institute, Lodz, Poland) PI (Subcontract To Genetics Research Institute) “Environmental cancer risk, nutrition and individual susceptibility” 5/1/05 – 4/30/08 (€177,000) European Commission Sixth Framework Program Enrico Garaci (Superior Institute of Health, Rome, Italy) PI (Subcontract To Genetics Research Institute) “EU Public Health Outcome research and Indicators Collection” 4/1/05 – 3/31/06 (€92,000)
SOCIETY MEMBERSHIPS:
Washington Academy of Sciences
American Scientific Affiliation (Fellow)
Biologos President’s Circle
American Association for Cancer Research
Society of Toxicology
American Chemical Society
New York Academy of Sciences
Mid‑Atlantic Society of Toxicology
TEACHING EXPERIENCE:
Director – Training Grant in Environmental Oncology NYU
Course Director – Graduate Program in Research Integrity NYU
Member – Graduate Steering Committee NYU
Courses Taught
NYU Department of Environmental Medicine:
Environmental Carcinogenesis
Genetic Toxicology
Biochemical Toxicology
Biomarkers
NYU School of Medicine:
Scientific Integrity
NYU School of Journalism:
Basic Fundamentals of Modern Biology
IARC/ISI International Course in Molecular Epidemiology:
Introduction To Molecular Biology And PCR
University of Pittsburgh:
Molecular Fundamentals of Environmental Health
Foundation for the Advancement of Education in the Sciences (FAES) at NIH:
Introduction to Environmental Health Science
Graduate Students (Ph.D.):
Andrew Hood, Ann Hochwalt, Mary Jean Sawey, Jose Morales, Frank Hubbard, Francis Crofts, Anita Ballesteros, Mary Felber, Alfred Wiedow, Stacy Lloyd
Post Doctoral Trainees:
Greg Cosma, Isaac Wirgin, Lydia Cox, Cheyl Grunwald, Guat-Lian Kramer, Nirmal Roy, Julie Trachman, Sabya Ganguly, Laura Gaspari, Valentina Paracchini, Jingyiang Chen
BOOKS and ARTICLES
Science Monographs
Garte, S. Book Review of Doubt is their product. Preventive Medicine 48:203–204, 2009
Wild C, Vineis P, and Garte S Molecular Epidemiology of Chronic Diseases. Wiley Press, London, 2008.
Garte, S. Genetic Susceptibility to Cancer Kluwer Press, Boston Dordrecht, 1998.
Garte, S.J. Molecular Environmental Biology Lewis Publishers. Boca Raton FL. 1994.
Mass Market
Garte S. The Works of His Hands: A Scientist’s Journey from Atheism to Faith Kregel Publications, Fall, 2019 Bronze Forward Indies Award for Religious Nonfiction.
Garte S. A decade of Breathing Easier. Ottowa Citizen Dec. 31 2009
Garte S. WHERE WE STAND: A Surprising Look at the Real State of Our Planet Amacom Press, Oct, 2007
For Publications, please see Publications page.